Understanding familial high eosinophil disease in families
Part of Blood & lymphatic clinical trials.
This study follows families with a genetic condition that causes high levels of white blood cells called eosinophils. Researchers want to understand how the disease develops and changes over time to help predict who may get worse and how to treat it better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a blood relative (parent, sibling, child, grandparent, cousin, etc.) of someone already diagnosed with familial hypereosinophilia
- You are between 1 and 100 years old
- You are willing to complete study visits and follow-up appointments for the duration of the study
- You (or your parent/guardian if under 18) can understand and sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study examines how eosinophils (a type of white blood cell) behave and function when they become abnormally high in the blood or tissues. Researchers want to understand these conditions better to potentially improve treatment options.
This trial tests if dupilumab, added to your current treatment, can help with remaining symptoms of hypereosinophilic syndrome (HES) like asthma, eczema, nasal polyps, or eosinophilic esophagitis. You may qualify if you're already on a biologic therapy that lowers eosinophils but still have bothersome symptoms.
This study follows people with long-term high eosinophils (a type of white blood cell) and related conditions to learn how the illness changes over time. It helps doctors understand patterns of organ involvement and outcomes, which may improve future care.
This study follows people with or suspected Hyper-IgE syndrome (a rare immune disorder causing repeated infections and skin problems) to understand how the condition develops, how best to manage it, and which genes are involved. Researchers also welcome healthy relatives of patients to help identify genetic patterns.
This trial studies different types of eosinophil cells in people with asthma, eosinophilic granulomatosis with polyangiitis (EGPA), or hypereosinophilic syndrome (HES). It also includes healthy volunteers. The goal is to better understand these cells in each condition.
This study collects information and biological samples to better understand what causes certain allergic/eosinophilic conditions. It may help researchers learn mechanisms and improve future care.
Hear when a new Eosinophilia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.